Original Article
Spinal Cord (2006) 44, 594–604. doi:10.1038/sj.sc.3101891; published online 24 January 2006
Effect of postinjury intravenous or intrathecal methylprednisolone on spinal cord excitatory amino-acid release, nitric oxide generation, PGE2 synthesis, and myeloperoxidase content in a pig model of acute spinal cord injury
- 1Department of Anesthesiology, Anesthesiology Faculty, Virginia Mason Medical Center, University of Washington, Seattle, WA, USA
- 2Department of Anesthesiology, University of Washington, Seattle, WA, USA
Correspondence: CM Bernards, Department of Anesthesiology, Anesthesiology Faculty, B2-AN, Virginia Mason Medical Center, University of Washington, 1100 Ninth Avenue, Seattle, WA, USA
Abstract
Study design:
Prospective, randomized, in vivo acute spinal cord injury in pigs.
Setting:
Department of Anesthesiology, University of Washington, Seattle, WA, USA.
Objectives:
To determine whether postinjury methylprednisolone could reduce the generation of known mediators of secondary neurological injury.
Methods:
Intrathecal microdialysis probes were used to sample cerebrospinal fluid (CSF) for measurement of PGE2, glutamate, and citrulline (a byproduct of nitric oxide generation), before and after spinal cord injury in anesthetized pigs. The spinal cord was removed at the end of the study for measurement of myeloperoxidase and methylprednisolone concentrations. Animals were randomly allocated to receive intravenous methylprednisolone (30 mg/kg bolus then 3.4 mg/kg/h), intrathecal methylprednisolone (5 mg bolus then 5 mg/h), or saline, beginning 30 min after the spinal cord was injured by using a modification of the Allen weight drop technique.
Results:
Spinal cord injury significantly increased the amount of glutamate, PGE2, myeloperoxidase, and citrulline, recovered from the CSF dialysates. However, neither intravenous nor intrathecal methylprednisolone administered after injury had any effect on the magnitude of the increase in any of the measured biochemicals. Intrathecal methylprednisolone administration produced a spinal cord methylprednisolone concentration that was eight times greater, and a plasma concentration that was 32 times less, than that achieved with intravenous administration.
Conclusions:
Contrary to earlier animal studies in which methylprednisolone was administered either before or immediately after spinal cord injury, we found no effect of intravenous or intrathecal methylprednisolone on any of the parameters measured when administered 30 min postinjury.
Keywords:
PGE2, nitric oxide, glutamate, aspartate, myeloperoxidase, methylprednisolone
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Bridging the gap in spinal cord regeneration
Nature Medicine News and Views (01 Sep 1996)
Stem cells in the injured spinal cord: reducing the pain and increasing the gain
Nature Neuroscience News and Views (01 Mar 2005)
